Proniras Corporation
PrivateLast Round
Series B
Feb 1, 2024
Total Funding Raised
$21.25M
Company Overview
Proniras Corporation is a biotechnology company developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Mental Health
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proniras Corporation Comps
Public and private peers based on sector, stage, and business model.
Proniras Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 1, 2024 | ||||
| Grant | Sep 17, 2020 | ||||
| Series A | Jul 12, 2019 | ||||
| Seed | Apr 27, 2018 |
Key People
Founding team and executive leadership
Proniras Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series B |
| WRF Capital | Series B, Seed |
| ARCH Venture Partners | Seed, Series B |
| Alexandria Venture Investments | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
| National Institute on Drug Abuse | Grant |
Proniras Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proniras Corporation's valuation, stock price, and market status.
